We Strategically Partner With Other Innovator Healthcare Companies 

                                                                                                            CLINICAL DEVELOPMENT      

We strategically partner and collaborate with other innovator healthcare companies to in-/out-license or co-develop therapeutic and preventative candidates in the clinical phase of the development process.

The DELTA HEALTH team members have extensive clinical drug development experience in the following therapeutic areas:

• Cardiovascular Diseases

• Dermatology

• Oncology

• Endocrinology

• Allergy

• Nephrology

• Hematology

• Neurology

• Oncology

• Ophthalmology

• Urology

• Pain Management

• Immunology / Autoimmune

• Pulmonary / Respiratory

• Psychiatry

• Rheumatology

• Infectious Diseases

• Central Nervous System

We also have experience in the clinical development of biologics, vaccines and medical devices. 

In addition to the United States Food and Drug Administration (FDA) and Health Canada, the DELTA team also has considerable experience in working with the European Medicines Agency (EMA), the Ministry of Health Mexico and Argentina Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT). 

​